Clinical Study
Perinatal Risks Associated with Early Vanishing Twin Syndrome following Transfer of Cleavage- or Blastocyst-Stage Embryos
Table 2
Comparison of ovarian stimulation parameters of patients undergoing cleavage-stage ETs (
) or blastocyst-stage ETs (
) with early VT.
| Parameter | Cleavage-stage () | Blastocyst-stage () | |
| Total days of ovarian stimulation | 9.77 (±1.49) | 9.41 (±1.12) | 0.06 | Total dosage of gonadotropins (IU) | 2992.7 (±329.1) | 2527.2 (±278.3) | <0.001 | Peak E2 level (pg/mL) | 1609.2 (±471.9) | 2259.0 (±512.3) | <0.001 | Peak endometrial thickness (mm) | 10.8 (±2.12) | 10.7 (±1.92) | 0.71 | Total number of oocytes | 12 (9–15) | 14 (9–17) | <0.001 | Total number of mature oocytes | 10 (7–13) | 12 (7–15) | <0.001 |
|
|
Data are presented as mean ± standard deviation, median (interquartile range), and (%); : estradiol.
|